Suchergebnisse - "Christensen, Britt"

PubPharm (11)

1

Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments

enthalten in: Gut | 2024

von Zhang, E. | Nguyen, T. | Allen, L. | +13

2

Tricks and traps of thioguanine : a case report of myelotoxicity

enthalten in: Internal medicine journal | 2023

von Elford, A. | Dimovski, S. | Christensen, B.

3

Letter : ozanimod and latent tuberculosis-authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Zhang, E. | Christensen, B.

CommentOn: Aliment Pharmacol Ther. 2023 Feb;57(3):353-354. - PMID 36641788

4

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Christensen, B. | Rubin, D.

CommentOn: Clin Gastroenterol Hepatol. 2020 Oct;18(11):2518-2525.e1. - PMID 31812654

5

Letter : SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Al-Ani, A. | Prentice, R. | Rentsch, C. | +1

CommentOn: Aliment Pharmacol Ther. 2021 Mar;53(6):764-765. - PMID 33599328

6

Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Prentice, R. | Al-Ani, A. | Bond, K. | +2

CommentOn: Dig Liver Dis. 2020 Jun;52(6):604-605. - PMID 32360133

7

Gastrointestinal ACE2, COVID-19 and IBD : Opportunity in the Face of Tragedy?

enthalten in: Gastroenterology | 2020

von Garg, M. | Christensen, B. | Lubel, J.

CommentOn: Gastroenterology. 2020 May;158(6):1831-1833.e3. - PMID 32142773

8

Letter : Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Prentice, R. | Al-Ani, A. | Christensen, B.

CommentOn: Aliment Pharmacol Ther. 2020 Oct;52(8):1414-1415. - PMID 33105972

9

Letter : ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Prentice, R. | Tjandra, D. | Garg, M. | +5

CommentOn: Aliment Pharmacol Ther. 2020 Jul;52(2):276-283. - PMID 32359205

10

Letter : is pneumococcal vaccination safe during the COVID-19 pandemic? Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Al-Ani, A. | Johnson, D. | Christensen, B.

CommentOn: Aliment Pharmacol Ther. 2020 Sep;52(5):919-920. - PMID 32852816